Literature DB >> 16206874

Androgen receptor and molecular mechanisms of male-specific gene expression.

Diane M Robins1.   

Abstract

Androgen's central role in male differentiation, fertility and aggression is evident from human pathologies and animal behaviour studies. Androgens directly regulate gene expression via the androgen receptor (AR), a member of the nuclear receptor superfamily. Nuclear receptors share a modular structure, with specialized domains for DNA binding, ligand binding, and transcriptional activation. Ligand-induced conformational changes in receptor trigger coregulators to modify chromatin structure. This in turn controls access of the transcriptional machinery to targeted genes. Given a common receptor structure and mode of action, AR must rely on several mechanisms for transcriptional specificity. As we have shown for the mouse sex-limited protein gene, these include use of divergent DNA binding sites, cooperativity between sites enhanced by intra- and intermolecular interaction of AR's N- and C-termini, and coactivator interactions. Although individual mechanisms lack sufficient specificity or strength, the summed interplay of response elements and accessory factor binding achieves precise gene activation. In addition to direct gene activation, AR elicits male-specific expression by modulating other hormonal pathways. For example, androgen control of growth hormone secretion induces male-specific genes in the liver. This sex-specific expression is further enforced by a novel class of KRAB zinc finger repressors. Their variation between species evidences diverging mechanisms of sexual differentiation, echoing AR's own recent origin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206874

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  7 in total

1.  Identification and characterization of an androgen-responsive Kap promoter enhancer located in the intron II region of human angiotensinogen gene.

Authors:  Li-qiang Fan; Dianne O Hardy; James F Catterall; Jian Zhao; Su-xia Li
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-12       Impact factor: 4.292

2.  Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.

Authors:  Mara P Steinkamp; Orla A O'Mahony; Michele Brogley; Haniya Rehman; Elizabeth W Lapensee; Saravana Dhanasekaran; Matthias D Hofer; Rainer Kuefer; Arul Chinnaiyan; Mark A Rubin; Kenneth J Pienta; Diane M Robins
Journal:  Cancer Res       Date:  2009-04-14       Impact factor: 12.701

3.  Fine mapping and candidate gene search of quantitative trait loci for growth and obesity using mouse intersubspecific subcongenic intercrosses and exome sequencing.

Authors:  Akira Ishikawa; Sin-ichiro Okuno
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

4.  Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats.

Authors:  Hyun Hwangbo; Da He Kwon; Eun Ok Choi; Min Yeong Kim; Kyu Im Ahn; Seon Yeong Ji; Jong Sik Kim; Kyung-Il Kim; No-Jin Park; Bum Hoi Kim; Gi-Young Kim; Su-Hyun Hong; Cheol Park; Ji-Suk Jeong; Yung Hyun Choi
Journal:  Nutr Res Pract       Date:  2018-07-23       Impact factor: 1.926

5.  The regulation and evolution of a genetic switch controlling sexually dimorphic traits in Drosophila.

Authors:  Thomas M Williams; Jane E Selegue; Thomas Werner; Nicolas Gompel; Artyom Kopp; Sean B Carroll
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

Review 6.  The androgen receptor as an emerging target in hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Osamu Yokosuka
Journal:  J Hepatocell Carcinoma       Date:  2015-06-26

7.  Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element.

Authors:  Steven Kregel; Pia Bagamasbad; Shihan He; Elizabeth LaPensee; Yemi Raji; Michele Brogley; Arul Chinnaiyan; Marcin Cieslik; Diane M Robins
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.